Comparative study on hemato- and nephrotoxicity profile of weekly versus every 3-weekly cisplatin dosage during induction chemotherapy in locally advanced head neck squamous cell carcinoma

Comparative study on hemato- and nephrotoxicity profile of weekly versus every 3-weekly cisplatin dosage during induction chemotherapy in locally advanced head neck squamous cell carcinoma

Abstract Background Cisplatin is a frontline anticancer drug routinely used as part of concurrent chemoradiation administered at 3-weekly (100 mg/m2) dose. However, its role as fractionated weekly dose has achieved favorable outcome in patients with locally advanced squamous cell carcinoma of head a...

Full description

Bibliographic Details
Main Authors: Adity Chakraborty, Abhinandan Bhattacharjee, Amlan Jyoti Nath, Shibashis Deb, Aakanksha Rathor
Format: Article
Language:English
Published: SpringerOpen 2021-07-01
Series:The Egyptian Journal of Otolaryngology
Subjects:
Induction chemotherapy
Squamous cell carcinoma of head and neck
Hematotoxicity
nephrotoxicity
Online Access:https://doi.org/10.1186/s43163-021-00145-2

Similar Items

Similar Items